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TUMOURS - THE RED CROSS
WAR MEMORIAL CHILDREN'S
HOSPITAL EXPERIENCE, 1980 - 1996
J D Daubenton, P S Hartley, H Rode, C C Sinclair-Smith
Objective. To document the experience of Red Cross War
Memorial Children's Hospital in the treatment of
sacrococcygeal germ-eell tumours.
Patients. Twenty-seven patients with sacrococcygeal germ-eell
tumours were treated in our hospital from 1980 to 1996.
Design. A retrospective review of these patients' records was
undertaken.
Results. There were 19 female and 8 male patients. Seventeen
(63%) presented in the neonatal period, 13 on the first day of
life. Complete surgical resection of the tumour was achieved
in all patients with mature or immature teratomas (20
patients) and in 2 neonates with malignant tumours. The first
of these 2 neonates, with a malignant teratoma, was not given
chemotherapy and remains well 10 years later. The second,
with a yolk-sac tumour, also received no initial
chemotherapy. He relapsed at the age of 9 months and was
successfully treated with repeat excision and chemotherapy.
All 5 patients first diagnosed after the age of 1 year had
malignant tumours. These patients had incomplete surgical
resection (3) or biopsy only (2), and 3 were successfully
treated with chemotherapy. One patient relapsed with yolk-
sac tumour after initial complete resection cif a mature
teratoma. She was successfully treated with repeat surgery
and chemotherapy.
5 Afr Med [1998; 88: 1592-1594.
December 199 , VO!. 0.12 SAMJ
Department of Paediatrics and Child Health, University of Cape Town, and
Oncology Service, Red Cross War Memorial Children's Hospital, Cape Town
J 0 Daubenlon, MD, FCP (SA)
P S Hartley, MB ChB, FCP (SA)
Deparlment of Paediatric SlIrgrry, University of Cape Town and Red Cross War
Memorial Children's Hospital, Cape Town
H Rode, MMed, FCS (SA), FRCS (Edin)
Department of Pathology, University of Cape To-urn and Red Cross War Memorial
Children's Hospital, Cape Town
C C Sinclair-Smith, MB ChB, MMed
ORIGINAL ARTICLES
Sacrococcygeal teratomas are the most common neoplasms in
the newbomY Those occurring at an older age have a much
higher risk of malignancy.'.' In a recent report from Nigeria' a
later age at presentation was noted compared with the
American experience, with 60% of patients presenting after the
third month of life. This study records the experience of a
single centre in Cape Town, South Africa.
PATIENTS AND METHODS
A total of 74 patients with germ-cell tumours were treated
between January 1980 and December 1996 at Red Cross War
Memorial Children's Hospital. Of the 49 with extragonadal
tumours, 27 had sacrococcygeal tumours. A review of these
patients' records was undertaken and the following
information recorded: age at diagnosis, sex, surgery
undertaken, histology, treatment and outcome.
RESULTS
Twenty-seven patients with sacrococcygeal tumours were
treated between January 1980 and December 1996. Of the 27
patients 7 (26%) had malignant tumours on initial histology.
The average age of those presenting with benign tumours was
36 days (range 1 day - 7 months), which is considerably less
than the average age of 19 months (range 1 day - 51 months)
for those with malignant tumours. Seventeen patients (63%)
presented in the neonatal period, 13 on the first day of life and
the other 4 within 14 days of delivery. Patient details are
summarised in Table 1. Fig. 1 shows an infant with a large
sacrococcygeal teratoma.
Complete surgical resection of the tumour was achieved in
all patients with mature or immature teratomas (20 patients)
and in the 2 neonates with malignant tumours. The first of
these 2 neonates, with a malignant teratoma, was not given
chemotherapy and remains well 10 years later. The second,
with a yolk-sac tumour, also received no initial chemotherapy.
He relapsed at the age of 9 months and was successfully
Fig. 1. Infant with a large sacrococcygeal teratoma.
treated with repeat excision and chemotherapy. He is alive and
free of disease 14 years later. Of the other 5 patients, all over
the age of 12 months at the time of diagnosis, 3 had incomplete
resection and 2 had biopsy only. Complete surgical resection
was not possible due to extensive local invasion. These 5
patients all had malignant histology. Three had a yolk-sac
tumour, 1 a mixed germ-cell tumour and 1 a malignant
teratoma.
Chemotherapy (cisplatinum, vinblastine, bleomycin,
etoposide) achieved a successful remission in the 3 patients
over 1 year of age with yolk-sac tumours, and they are alive
and disease-free 8, 11 and 12 years after diagnosis. The patient
with the mixed germ-cell tumour, after an initial response to
cisplatinum, etoposide and bleomycin, developed progressive
disease and died without ever achieving a complete remission.
The patient with the malignant teratoma responded to a
combination of vincristine, adriamycin, cyclophosphamide,
cisplatinum, etoposide and bleomycin, but relapsed 10 months
later and died of disease.
A 3-month-old girl, initially diagnosed as having a mature
tumour, relapsed with a yolk-sac tumour 21 months after initial
Table I. Details of 27 patients with sacrococcygeal germ-cell tumours treated at Red Cross Hospital 1980 - 19%
Initial histology Outcome
Age Patients Mature Immahrre Malignant A D L
Neonate 17 8 7 2 15 1* 1
1 - 6 months 4 3 1 0 3 0 1
6 -12 months 1 1 0 0 1 0 0
12 - 24 months 3 0 0 3 3 0 0
24 - 36 months 1 0 0 1 0 1 0
> 36 months 1 0 0 1 0 1 0
Total 27 12 8 7 22 3 2
Sex: female 19, male 8, ratio 2.37:1-
'Cause of death not related to the tumour.
A =alive and disease-free, D =dead, L =lost to follow-up.
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diagnosis. She underwent repeat surgical excision and received
chemotherapy (cisplatinurn, vinblastine, bleomycin, etoposide)
and is alive and free of disease 10 years later.
The 2 patients lost to follow-up were both followed for less
than a year and then lost to long-term follow-up. One had a
mature and the other an immature teratoma and both were
well when last seen.
DISCUSSION
The 26% incidence of malignancy (at presentation),
predominantly in older children, the high proportion
presenting in the neonatal period with benign tumours and the
preponderance of female patients in this series are similar to
findings in a number of previously reported American series,'''
but different from an African series that showed a later
presentation age.'
Surgical principles included a chevron gluteal incision and
removal of the coccyx and all macroscopic tumour en bloc.
Presacral extension should be identified clinically with pre-
operative imaging as this is often the area most problematic in
ensuring complete surgical removal.
Recurrence with a yolk-sac tumour in an apparently benign
tumour is unusual, but this has been well described with
immature tumours.-' In some cases of surgically excised
immature sacrococcygeal teratomas that recurred as yolk-sac
tumours, careful review of the original slides has shown
microscopic foci of yolk-sac tumour that were not identified
initially.- A recent case report found yolk-sac tumour at autopsy
in a patient with an immature sacrococcygeal teratoma
apparently completely excised? The intra-pelvic recurrence, in
this series, of an apparently non-malignant extrapelvic tumour
21 months after surgery emphasises the need for follow-up of
all patients.
The low incidence of malignancy in patients with
sacrococcygeal teratomas presenting under a year of age is
encouraging, as is the favourable outcome in our newborn
patients with malignant tumours.
The success with chemotherapy in 5 of the 7 patients with
malignant tumours emphasises the importance of early referral
of these patients to a recognised paediatric oncology centre
where adequate management, including appropriate
chemotherapy, can be given. Mutilating surgery is not
indicated as chemotherapy can successfully ablate residual
local disease. Overall cure rates approaching 90% following
treatment with carboplatin, bleomycin and etoposide have
ImI been reported recently.'
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